Oriental Biotech announced that the company recently obtained a number of medical device registration certificates from the European Union, Switzerland and the United Kingdom, covering instruments such as fully automatic biochemical analyzers and fluorescence immunoassay analyzers, as well as various test kit products such as beta-human chorionic gonadotropin, D dimer, N-terminal natriuretic peptide precursor, and myocardial troponin I. The above evidence has enriched and perfected the company's market layout in the field of fluorescence immunoassay and biochemical testing in Europe. There is uncertainty about the actual sales performance of the product, and it is not yet possible to predict the impact on the company's future business performance.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.